Vivani Medical Achieves 1st Implant & Full Enrollment in Overweight Trial
By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) announced it finished the placement of NPM-115,...
By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) announced it finished the placement of NPM-115,...
By Karen Roman Vivani Medical, Inc. (Nasdaq: VANI) said it expects to spin off Cortigent,...
By Karen Roman Grove Collaborative Holdings, Inc. (NYSE: GROV) said annual adjusted EBITDA was $1.3...
By Karen Roman Biopharmaceutical company Medera Inc. said it finished patient dosing in the trial...
By Daniella Parra Kohl’s Corporation (NYSE: KSS) said net sales fell 9.4% and 7.2% for...
By Karen Roman The ONE Group Hospitality, Inc. (Nasdaq: STKS) said fourth quarter revenue increased...
By Daniella Parra Potbelly Corp. (Nasdaq: PBPB) said its average weekly sales increased 1.1% to...
By Karen Roman a.k.a. Brands Holding Corp. (NYSE: AKA) said fourth quarter net sales increased...
By Daniella Parra Ascentage Pharma (NASDAQ: AAPG; HKEX) said that its drug Olverembatinib is the...
Muslim Pro CEO Nafees Khundker says, “[Our] vision [is] to be the digital home for...